The impact of physical activity on health in breast cancer survivors Not Applicable
Conditions
Interventions
The study will include women treated for non-disseminated breast cancer in Oncology Centre in Katowice.
The intervention will consist of two stages. In the first stage, after the medi
Sponsors
Akademii Wychowania Fizycznego im. Jerzego Kukuczki w Katowicach
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Patient's written consent to participate in the study 2. Age 30 - 70 years 3. First treatment of non-disseminated breast cancer 4. 0 - III degree of cancer 5. Overweight and obesity (BMI >25 kg/m²) 4. Treatment of breast cancer (mastectomy and minimally invasive surgery) 5. Adjuvant treatment (chemotherapy, immunotherapy, hormone therapy, radiotherapy) based on the medical indications 6. Completed radiotherapy and chemotherapy from 4 weeks to 6 months before the study start 7. No physical training for more than 60 minutes a week before the start of the study 8. Hormone therapy and/or immunotherapy, 9. Minimum of 5 years from the end of treatment for another malignant tumor
Exclusion criteria
Exclusion criteria: 1. Contraindications to physical training at the intensity specified in the study 2. Refusal to participate in the study 3. Co-morbidities disrupting the body’s balance including diseases of the nervous system, balance organ, eyes, muscles and joints (amputations, unequal limb length >2 cm, joint stiffness and limited range of movement in lower extremities above 15 degrees)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Quality of life assessed with the EORTC QLQ – C30 - Quality of Life Questionnaire of Cancer Patients at baseline, after finishing 6-week physical training and 6 weeks after treatment 2. Quality of life assessed with the EORTC QLQ – BR 23 - Quality of Life Questionnaire for Breast Cancers at baseline, after finishing 6-week physical training and 6 weeks after treatment 3. Postural stability assessed by AMTI's AccuGait Optimized™ multi-axis force platform tests at baseline, after finishing 6-week physical training and 6 weeks after treatment 4. Postural stability assessed by Timed Up and Go test (TUG) at baseline, after finishing 6-week physical training and 6 weeks after treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Physical activity level assessed by Physical Activity Questionnaire (IPAQ) questionnaire at baseline, after finishing 6-week physical training and 6 weeks after treatment 2. Fatigue level assessed by Brief Fatigue Inventory (BFI) at baseline, after finishing 6-week physical training and 6 weeks after treatment 3. Locomotor function assessed by 4-Meter Gait Speed test (4MGS) at baseline, after finishing 6-week physical training and 6 weeks after treatment 4. Pain is measured using a visual analogue scale (VAS) at baseline, after finishing 6-week physical training and 6 weeks after treatment 5. Fall risk is measured using the Falls Efficacy Scale-International (FES-I) at baseline, after finishing 6-week physical training and 6 weeks after treatment | — |
Countries
Poland
Outcome results
None listed